Walid Mustafa is the CEO of NuVeta Radiotherapy. Mr. Mustafa graduated from North Carolina State University with a BS in Economics. Mr. Mustafa is an experienced and dedicated entrepreneur with a proven track record of success in a variety of businesses related to software development, specialty materials, electronic medical records and medical devices. In addition to his technical skills, Mr. Mustafa is a strong communicator and motivator. He fosters a positive and inclusive work environment and is committed to supporting the professional development of his team. Under Mr. Mustafa’s leadership at NuVeta, the team has consistently exceeded performance goals and delivered excellent results. Moving forward, his vision for NuVeta is to continue driving innovation and expanding the company’s reach globally. Mr. Mustafa is a dedicated husband and father of 2 boys. When he’s not at work, he enjoys playing tennis and spending time with his family.

Dr. Sha Chang received her Ph.D. from Clark University and doing a Medical Physics Residency at The Joint Cent for Radiotherapy at Harvard Medical School. Dr. Chang is a Professor and Director of Medical Physics Research at UNC-Chapel Hill.

Dr. Chang has three decades of academic clinical physics including clinical service, education, R&D, and management. Dr. Chang also has two decades of innovative multidisciplinary research including the nanotechnology based SFRT preclinical system development and SFRT research. This experience makes gives Dr. Chang world leading expertise in SFRT research and clinical application including meetings, a book chapter, and publications nationally & internationally.

Dr. Zhang has over twenty years of research and development experience with nanotechnology-based X-ray technology. He was one of the leading inventors for the first nanotube-based X-ray tube, the first nanotube CT scanner, and the first multi-beam stationary X-ray source. Over the years, Dr. Zhang has authored/co-authored more than 30 papers published in the field of nanotechnology and X-ray imaging. He is also the inventor/co-inventor of over 40 U.S. and international patents/patent applications. He was also trained for clinical radiation therapy treatment. He was awarded a Ph.D. in physics from UNC-Chapel Hill in 2005.

Dr. Cheng was the leading inventor of Few Walled carbon nanotubes (FWNTs) with enhanced field emission properties. He has published over twenty publications and has over ten patents and patent applications in nanomaterials and nanotechnology. In addition, Dr. Cheng Qian has been involved in many industrial and government projects as a principal investigator and key personnel. Furthermore, Dr. Cheng Qian has been leading and participating in large-scale manufacturing carbon nanotubes, carbon nanotube cathodes, and carbon nanotube X-ray tubes in the past years. He was awarded a Ph.D. in chemistry from Duke University in 2007.

Mr. Wise has broad senior level corporate and entrepreneurial experience in Finance, Product Development, Sales, Marketing and Licensing. Experience includes pharmaceuticals, diagnostics and medical equipment across a broad range of medical and industrial areas. Mr. Wise began his career with commercial and licensing positions at Ohmeda, Burroughs Welcome and Glaxo Welcome. After which Mr. Wise has been involved in all stages and roles in multiple startup ventures including fundraising, finance, buildout, operations, strategic agreements and planning. This included the role of CFO for Enhance Biotech. Mr. Wise has a degree in Industrial and Systems Engineering from the Georgia Institute of Technology along with a Masters in Business Administration from the Darden School at the University of Virginia.

David L. Grange is a retired United States Army major general. He served 30 years in the U.S. Army, leading from platoon through division level. Post his military career, he served in the McCormick Foundation for over 9 years, as President and CEO. After that, he was the CEO of Pharm-Olam International, LLC. Grange holds a bachelor’s degree from North Georgia College and a master’s in public service from Western Kentucky University. In addition, he is the recipient of an honorary Doctor of Humane Letters degree from both Johnson & Wales University and from Aurora University. Grange is in the Ranger Hall of fame, the Georgia Military Veterans Hall of Fame and is a University System of Georgia Distinguished Alumnus.

Dr. Michael Harris is the Chief Medical Officer and Chief Operating Officer for NuVeta Radiotherapy. Dr. Harris grew up in Chicago and graduated from The University of Tulsa with a Bachelor of Science degree. He obtained his doctorate at the University of South Carolina School of Medicine where he also did his Family Practice Residency training. Dr. Harris has been in practice for over 37 years and is Managing Partner and Chairmen of the Board for Lexington Family Practice comprised of 45 Physicians and 20 Mid- Level Practitioners with 12 locations. He has also served on many committees and Chairs of Boards for Hospital for New Business Development and Critical Emergency Teams during the Covid Pandemic.

His entrepreneur spirit and proven exceptional business acumen has led him in many diverse successful businesses in Logistics, Sports Complexes, Trucking and the Luxury Charter industry. His strengths in new business development are founded in ethical business practices with a clear laser focus on structuring teams and implementing business plans with expert key team members in their perspective fields to ensure success. This synergistic approach has brought together many Dream Teams over the years which he has thoroughly enjoyed building and managing.

Dr. Harris has been blessed with a wonderful wife, and is a devoted father to four children and seven grandchildren. He enjoys Golf, Pickle-Ball and Travel.